1[1]Yamaha S, Sugimoto N, Uchida S, etal. Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors[J]. J Cardiovasc Pharmacol, 1994,23(3) :466 - 472. 被引量：1
2[2]Nordlander M, Abrahamasson T, Akerblom B, et al. Vascular versus myocardial selectivity of dihydropyridine calcium antagonists as studied in vivo and in vitro[J]. Pharmacol Toxicol, 1995,76(1) :56- 62. 被引量：1
3[3]Elkayam U, Amin J, Mehra A, et al. A prospective, randomized,double- blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure[J].Circulation, 1990,82(6): 1954 - 1961. 被引量：1
4[4]Goldstein RE, Boccuzzi SJ, Cruess D, et al. Diltiasem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction[J]. Circulation, 1991,83(1) :52 - 60. 被引量：1
5[5]Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction[J]. N Engl J Med,1988,319(7):358- 392. 被引量：1
6[6]Packer M, Nicod P, Bijoy R, et al. Randomized, multicenter, double- blind, placebo - controlled evaluation of amlodipine in patients with mild-moderate heart failure[J]. J Am Coll Cardiol, 1991,17(2):274A. 被引量：1
7[7]Packer M, Christopher M, O' Connor CM, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure[ J]. N Engl J Med, 1996,335(15): 1107 - 1114. 被引量：1
8[8]Kloner RA, Sowers JR, DiBona GF, et al. Effect of amlodipine on left ventricular mass in the amlodipine cardiovascular community trial[J].J Cardiovase Pharm. acol, 1995,26:471-476. 被引量：1
9[9]Lombardo M, Alli C, Broccolino M,et al. Long- term effects of angiotensin- converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension [ J ]. Am Heart J,1997,134(3) :557 - 564. 被引量：1
10[10]Chou TC, Li CY, Yen MH,et al. Antiplatelet effects of amlodipine:a possible mechanism through a nitric oxide mediated process [J].Biochem Pharmcol, 1999,58(10): 1657 - 1663. 被引量：1
